Heart Test Laboratories Inc (HSCS) concluded trading on 12/27/23 at a closing price of $0.17, with 2.94 million shares of worth about $0.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.06% during that period and on Wednesday the price saw a loss of about -3.57%. Currently the company’s common shares owned by public are about 10.12M shares, out of which, 8.77M shares are available for trading.
However, the stock later moved at a day high price of 0.1730, or with a loss of -3.57%. Stock saw a price change of -0.78% in past 5 days and over the past one month there was a price change of -23.08%. Year-to-date (YTD), HSCS shares are showing a performance of -80.35% which decreased to -81.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.14 but also hit the highest price of $3.95 during that period. The average intraday trading volume for Heart Test Laboratories Inc shares is 8.54 million. The stock is currently trading -11.28% below its 20-day simple moving average (SMA20), while that difference is down -24.79% for SMA50 and it goes to -76.43% lower than SMA200.
Heart Test Laboratories Inc (NASDAQ: HSCS) currently have 10.12M outstanding shares and institutions hold larger chunk of about 4.85% of that.
The stock has a current market capitalization of $1.85M and its 3Y-monthly beta is at 3.66. It has posted earnings per share of -$0.61 in the same period. It has Quick Ratio of 0.15. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HSCS, volatility over the week remained 8.11% while standing at 12.32% over the month.
Analysts are in expectations that Heart Test Laboratories Inc (HSCS) stock would likely to be making an EPS of -$0.06 in the current quarter, while forecast for next quarter EPS is -$0.03 and it is -$0.14 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.06 which is -$0.06 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.16 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 68.75% while it is estimated to increase by 44.00% in next year.
Analysts at 1 brokerage firms have issued recommendations for the Heart Test Laboratories Inc (HSCS)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
